ROOT-ADNCT07923812
Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Secondary (9)
Show 4 moreShow less
Arms and interventions
The disease-modifying therapy group includes patients with MCI-AD or AD dementia who received disease-modifying therapy during routine clinical practice. Patients were diagnosed based on clinical criteria and available biomarker evidence according to real-world clinical practice. Baseline characteristics, treatment information, clinical outcomes, and safety data will be retrospectively collected and analyzed.
The non-disease-modifying therapy group includes patients with MCI-AD or AD dementia who did not receive disease-modifying therapy. Patients may have received conventional symptomatic treatments or other non-disease-modifying treatments according to routine clinical practice. Clinical characteristics, treatment information, clinical outcomes, and safety data will be retrospectively collected and analyzed.
Drugs: Disease-Modifying Therapy
Sites
1 site in 1 country
- Huashan Hospital, Fudan University, No. 12 Wulumuqi Middle Road, Jing'an District, ShanghaiShanghai, Jingan, China